Have you or your loved ones been diagnosed with brain neoplasms?

You may be eligible to participate in a brain neoplasms clinical trial.

Have you or your loved ones been diagnosed with brain neoplasms? You may be eligible to participate in a brain neoplasms clinical trial.

What is a clinical trial? Is participating in a clinical trial right for you? Learn more

Brain Neoplasms Clinical Trial in Boston MA
NCT02667587 | Phase 3 | Interventional
Bristol Myers Squibb
Sponsored by
Bristol Myers Squibb

Have you or your loved ones been diagnosed with brain neoplasms?

You may be eligible to participate in a brain neoplasms clinical trial.

Have you or your loved ones been diagnosed with brain neoplasms? You may be eligible to participate in a brain neoplasms clinical trial.

Active not recruiting

Male & Female

18 Years +

This study has recruited 716 Participants

The purpose of this study is to evaluate patients with glioblastoma that is MGMT-methylated (the MGMT gene is altered by a chemical change). Patients will receive temozolomide plus radiation therapy. They will be compared to patients receiving nivolumab in addition to temozolomide plus radiation therapy.